Role of CD44/HA Pathway in Regulation of Neural Stem Cell Fate

Information

  • Research Project
  • 7094220
  • ApplicationId
    7094220
  • Core Project Number
    K18HL081096
  • Full Project Number
    5K18HL081096-02
  • Serial Number
    81096
  • FOA Number
    PAR-02-069
  • Sub Project Id
  • Project Start Date
    7/15/2005 - 18 years ago
  • Project End Date
    6/30/2007 - 16 years ago
  • Program Officer Name
    BISHOP, TERRY ROGERS
  • Budget Start Date
    7/1/2006 - 17 years ago
  • Budget End Date
    6/30/2007 - 16 years ago
  • Fiscal Year
    2006
  • Support Year
    2
  • Suffix
  • Award Notice Date
    6/23/2006 - 17 years ago
Organizations

Role of CD44/HA Pathway in Regulation of Neural Stem Cell Fate

DESCRIPTION (provided by applicant): Stem cells, both embryonic and somatic, theoretically hold great promise for tissue regeneration and the restoration of organ function in human diseases. In particular, the purification and characterization of human neural stem cells (hNSCs) has shown potential for neural repair and the development of new hNSC-based transplantation strategies for the treatment of aspects of eurodegenerative disorders. However, a lack of understanding of the mechanisms by which the local microenvironment regulates the fate of hNSCs reflects a gap in our knowledge of fundamental stem cell biology and remains one of the obstacles to effective therapies. Extracellular matrix (ECM) contributes to the complex structure of the brain's neurogenic microenvironment. In addition to providing structure, hyaluronic acid (HA), a major component of the ECM, possesses a regulatory function via its interactions with CD44, its cell surface receptor, which is expressed by hNSCs. Micro array analysis suggests that high molecular weight HA significantly changes the expression of 24 genes, at least two. MFRP (membrane-type frizzled-related protein) and ICDAP-1alpha (integrin cytoplasmic domain-associated protein-1 alpha) can determine the behavioral choices of hNSCs. This K18 training grant application, sponsored by Dr. Evan Snyder, director of The Burnham Institute's Stem Cell Program, is designed to address the question of how the CD44/HA pathway regulates the fate of hNSCs. Based on our preliminary data, we hypothesize that HA contributes to the neurogenic regulatory network by interacting with CD44 expressed on hNSCs and initiating signal transduction pathways that subsequently result in differential gene expression and the reprogramming of hNSCs behavior. In Specific Aim #1, we will investigate the effect of HA on cytoskeleton organization and MAPK phosphorylation in hNSCs. In Specific Aim #2, we will examine the effect of HA on the expression of MFRP and ICDAP-1alpha and whether the effect of HA on the differential expression of MFRP and ICDAP-1alpha is mediated by CD44 in hNSCs. Overall, in addition to providing training opportunities, this proposal will allow us to test a novel hypothesis and to generate data for further studies on the role of the CD44/HA pathway in regulation of hNSCs fate.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    K18
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    54067
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
    NHLBI:54067\
  • Funding Mechanism
  • Study Section
    ZHL1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LA JOLLA INST FOR MOLECULAR MEDICINE
  • Organization Department
  • Organization DUNS
    941462285
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921213074
  • Organization District
    UNITED STATES